AccessDX
AccessDx Laboratory is dedicated to providing clinical insights that improve patient outcomes through advanced laboratory diagnostics solutions, including COVID-19 testing, pharmacogenomic testing, cancer genomic testing, and infectious disease testing. The company is CLIA-certified, CAP-accredited, and NYSDOH-approved, serving thousands of healthcare providers nationwide with a commitment to clinical excellence, innovation, and health equity.
Industries
Nr. of Employees
large (251-1000)
AccessDX
Houston, Texas, United States, North America
Products
PGx targeted gene panel
A clinically selected panel of genes and variants to assess medication-related genetic risk across therapeutic areas with clinician-facing interpretive reports.
UTI diagnostic panel (molecular + culture + AST)
Combined molecular detection of common UTI pathogens and resistance markers with culture-based antibiotic sensitivity to support rapid and confirmatory clinical decisions.
Population health and medication risk management platform
Platform functionality for real-time medication monitoring, alerts, cohort analytics, and program analytics to support medication-safety initiatives at facility and network scale.
PGx targeted gene panel
A clinically selected panel of genes and variants to assess medication-related genetic risk across therapeutic areas with clinician-facing interpretive reports.
UTI diagnostic panel (molecular + culture + AST)
Combined molecular detection of common UTI pathogens and resistance markers with culture-based antibiotic sensitivity to support rapid and confirmatory clinical decisions.
Population health and medication risk management platform
Platform functionality for real-time medication monitoring, alerts, cohort analytics, and program analytics to support medication-safety initiatives at facility and network scale.
Services
Pharmacogenomics testing service and interpretive reporting
Targeted PGx panel testing with clinical interpretation to identify drug-gene interactions and support medication optimization.
Molecular infectious disease testing
PCR-based pathogen detection and reporting for infectious disease diagnosis and stewardship initiatives.
Combined molecular + culture UTI testing (molecular speed + culture confirmation)
Service combining rapid molecular detection of urinary pathogens and resistance markers with culture and AST to enable faster and confirmatory clinical decisions.
Clinical decision support and medication risk monitoring (EHR-integrated) service
Continuous drug-gene monitoring and pharmacogenomic risk alerts delivered into clinical workflows and EHRs to help identify and remediate medication risks.
Variant detection and genomic surveillance (investigational)
Investigational variant-detection services using sequencing to identify emergent pathogen variants from PCR-positive samples, offered as a surveillance capability.
Pharmacogenomics testing service and interpretive reporting
Targeted PGx panel testing with clinical interpretation to identify drug-gene interactions and support medication optimization.
Molecular infectious disease testing
PCR-based pathogen detection and reporting for infectious disease diagnosis and stewardship initiatives.
Combined molecular + culture UTI testing (molecular speed + culture confirmation)
Service combining rapid molecular detection of urinary pathogens and resistance markers with culture and AST to enable faster and confirmatory clinical decisions.
Clinical decision support and medication risk monitoring (EHR-integrated) service
Continuous drug-gene monitoring and pharmacogenomic risk alerts delivered into clinical workflows and EHRs to help identify and remediate medication risks.
Variant detection and genomic surveillance (investigational)
Investigational variant-detection services using sequencing to identify emergent pathogen variants from PCR-positive samples, offered as a surveillance capability.
Expertise Areas
- Pharmacogenomics
- Molecular infectious disease diagnostics
- Hereditary cancer genomics
- Clinical decision support and EHR integration
Key Technologies
- Polymerase chain reaction (PCR)
- Next-generation sequencing (NGS)
- Microbiology culture and antibiotic susceptibility testing (AST)
- Bioinformatics for clinical reporting